1 active trials 0 recruiting 1 Phase 3 1 disease areas
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06790966 | Phase 3 Study of PDS0101 and Pembrolizumab in HPV16+ Recurrent/Metastatic Head and Neck… | Recurrent Head and Neck Cancer | Active, Not Recruiting | 2026-04-06 |